Flecainide is associated with a reduction in arrhythmic events in a large cohort of patients with catecholaminergic polymorphic ventricular tachycardia

FUNDING ACKNOWLEDGEMENTS: Type of funding sources: Public grant(s) – National budget only. Main funding source(s): This work was supported by the ZonMW Priority Medicines for Rare Diseases and Orphan Drugs (grant 113304045 to Dr Van der Werf) and the Netherlands CardioVascular Research Initiative: t...

Descripción completa

Detalles Bibliográficos
Autores principales: Bergeman, A T, Tanck, M W, Kallas, D, Sanatani, S, Leenhardt, A, Ackerman, M J, Till, J, Zorio, E, Kannankeril, P J, Kammeraad, J A E, Aiba, T, Semsarian, C, Robyns, T, Wilde, A A M, Van Der Werf, C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
13.4.2 - Drug Treatment of Ventricular Arrhythmias
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207234/
http://dx.doi.org/10.1093/europace/euad122.301

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10207234/
http://dx.doi.org/10.1093/europace/euad122.301

Ejemplares similares